Project Apollo

An approach to treat PKAN, ALS and PNH

Rubix LS has developed a unique approach to hemoglobin, protein and synthetic cell modification; this combination device is targeting a multi- faceted approach in treating:

Pantothenate Kinase-Associated Neurodegeneration (PKAN) to Amyotrophic Lateral Sclerosis (ALS) & Paroxysmal Nocturnal Hemoglobinuria (PNH) to Lewy Body Dementia